2015 ASCO AM Public Saturday - ASCO


Powered by SmugMug Log In
Leukemia, Myelodysplasia, and Transplantation Oral Abstract Session

Leukemia, Myelodysplasia, and Transplantation Oral Abstract Session

Chicago, IL - 2015 ASCO Annual Meeting - Ruben A. Mesa, MD, presenting abstract LBA7006, Results of the PERSIST-1 phase III study of pacritinib (PAC) versus best available therapy (BAT) in primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia-myelofibrosis (PET-MF). during Leukemia, Myelodysplasia, and Transplantation Oral Abstract Session at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Saturday, May 30, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Zach Boyden-Holmes 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org

ASCO2015ZBH0499.jpgAM15_Communications